COLL - MCAP CO - Collegium Pharmaceutical

Collegium Pharmaceutical (COLL) relies on a broad portfolio of pain management products, which minimizes risks associated with individual brands, while operating exclusively within the US eliminates the impact of global conflicts. The confirmed price history on this chart, where the market capitalization stands at 0.73, demonstrates business stability. Demand for chronic condition therapies is independent of GDP, making the model resilient to economic downturns.

Market capitalization is calculated as the product of the current share price and the total number of outstanding securities, measuring the aggregate value of the business in the eyes of investors. For Collegium Pharmaceutical (COLL), this metric reflects the company's resilience to macroeconomic shocks due to the low cyclicality of demand for pain medications, as clearly demonstrated by the issuer's current market valuation.